Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P090015/S014

BOND Oracle HER2 IHC System

Leica Biosystems · Decision date Jun 4, 2026

FDA DECISIONP090015/S014

What did the FDA decide?

FDA records P090015/S014 as a supplement to PMA P090015, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jun 4, 2026.

FDA approval order statement

a manufacturing QC change
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Pathology
Decision date
Jun 4, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P090015/S014
Regulatory pathway
PMA supplement
Product code
MVC
Decision code
OK30
Decision date
Jun 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, TEST, HER-2/NEU, IHC.

Product code
MVC
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P090015/S014 received

    Application receipt date recorded by FDA.

  2. P090015/S014 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P090015. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MVC

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Leica Biosystems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
36 Cherry Hill Dr., Danvers, MA, 01923

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records